Showing results (371-380 of 686) with videos related to

Sort By:
Pageof 69
Alcoholism, Clinical and Experimental Research|October 6, 2017
Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT ConsortiumMegan Comerford, Spencer Lourens, Suthat Liangpunsakul, et al.
Hepatology Communications|September 24, 2021
Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol-Associated HepatitisDaniel D Penrice, Serena Shah, Camille A Kezer, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatideMark L Hartman, Rohit Loomba, Eric J Lawitz, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2007
Hypercoagulation and thrombophilia in liver diseaseP G Northup, V Sundaram, M B Fallon, et al.
JCI Insight|December 13, 2016
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitisRyan E Feaver, Banumathi K Cole, Mark J Lawson, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytesSayed Obaidullah Aseem, Grayson Way, Jing Wang, et al.
Gut|June 29, 2014
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesisCarlos J Pirola, Tomas Fernández Gianotti, Gustavo O Castaño, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2014
Urinary biomarkers and progression of AKI in patients with cirrhosisJustin M Belcher, Guadalupe Garcia-Tsao, Arun J Sanyal, et al.
Hepatology (Baltimore, Md.)|December 31, 2013
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injuryJustin M Belcher, Arun J Sanyal, Aldo J Peixoto, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2025
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASHBrent A Neuschwander-Tetri, Heather L Morris, Andrea R Mospan, et al.
Pageof 69